MiraVista Diagnostics Lateral Flow Assay | Lab Animation

Added:

Molecular and Quantitative Diagnostics (PCR/ELISA) vs. Rapid Lateral Flow Assays

While lateral flow assays (LFAs) offer rapid, low-cost, point-of-care results, they are frequently criticized for their lower sensitivity and specificity compared to laboratory-based molecular and quantitative diagnostics. LFAs typically provide qualitative (yes/no) or semi-quantitative results and have a higher limit of detection, meaning they may miss early-stage infections or low concentrations of an analyte, leading to false negatives. In contrast, molecular techniques like Polymerase Chain Reaction (PCR) and enzyme-linked immunosorbent assays (ELISA) offer superior sensitivity, exact quantification, and lower detection limits. Proponents of laboratory-based methods argue that for critical diagnoses—such as systemic fungal infections—molecular assays and quantitative ELISAs remain the gold standards, as they significantly reduce diagnostic errors and allow clinicians to monitor disease progression and treatment efficacy with high precision.

Fundamental principles of antigen-antibody binding specificity and immunological affinity.
The concept of capillary action and chromatography, specifically how fluids migrate through a porous membrane without external pump assistance.
Basic mechanics of conjugation, specifically how antibodies are conjugated to signal-producing markers like colloidal gold or latex beads.
The functional difference between test lines (which capture target analytes) and control lines (which verify test validity) in rapid diagnostics.
Advanced assay design strategies, including multiplexing to detect multiple target analytes simultaneously on a single strip.
Quantitative lateral flow assays, which utilize digital optical readers or smartphone-based detection to measure analyte concentration.
Troubleshooting assay sensitivity and specificity, including how to mitigate issues like the 'hook effect' and non-specific background binding.
Comparative analysis of lateral flow assays against laboratory standards like ELISA and PCR in clinical diagnostic settings.
458.4K views1likes2:10@miravistadiagnosticsOriginal Release: 2023-02-22

Lateral flow assays are diagnostic test devices that detect the presence of specific substances (such as antigens, antibodies, or biomarkers) in a sample by using a combination of a sample pad, conjugate pad, nitrocellulose membrane with test and control lines, and absorbent pad, where the sample flows laterally through the membrane and produces visible lines indicating positive or negative results.